As such, Fan et al. demonstrated LOXL2 activates the SNAIL/fructose-1,6-biphosphatase (FBP1) axis to upregulate the HIF-1α/VEGF pathway in HCC cells, leading to enhanced tubular networks of endothelial cells [49]. Here, LOXL2 is linked to hepatocellular carcinoma.